Corporate History (Timeline)Corporate History
The Journey of NOSTER
Bringing the light of science into the future.
-
2010
October
At BioJapan (Yokohama), Kohey Kitao met Professor Jun Ogawa of Kyoto University, marking the
beginning of the metabolite research that would later lead to NOSTER. Every journey begins with a single encounter. -
2013
October 29
The gut microbial metabolic pathway of linoleic acid was elucidated for the first time.
(Kishino et al., The Proceedings of the National Academy of Sciences, 2013) A new light entered the world of metabolite science.
-
2014
May
Selected for a NEDO research grant.
Development of the pilot production system for HYA began. Transforming scientific possibilities into reality. -
2015
January 30
The role of HYA in intestinal barrier function was reported.
(Miyamoto et al., Journal of Biological Chemistry, 2015) Opening a new perspective on biological homeostasis. -
2017
March
A Newsweek advertisement led to the first connection with AAAS and Science that would later
shape NOSTER’s global outlook. The moment the world began to notice NOSTER.August
Introduction of the NOSTER corporate identity.
The square symbol and deep blue color were designed to represent scientific integrity, creativity,
and trust. The first expression of who we are.
-
2019
May
Establishment of the NOSTER Bio Research Institute.
A dedicated research platform was created to support the translation of research into practical applications. From individual pursuit to collaborative innovation.July 23
Launch of the NOSTER & Science Microbiome Prize.
Established in collaboration with Science to support emerging scientists worldwide. Passing the light to the next generation of discovery.
September 5
A study examining HYA in obesity and metabolic regulation was published.
(Miyamoto et al., Nature Communications, 2019) A milestone toward metabolite-based drug discovery. -
2020
May 15
Noster inc. was established.
A new organization was created to bring scientific discoveries into society. Science creates value only when it reaches people. -
2021
January 18
Launch of CUMEC, NOSTER’s healthcare D2C brand.
A new step toward bringing science into everyday life. Science begins its journey into daily living.
July
Selected for a NEDO project to develop a fully automated HYA production system. Advancing the future of biomanufacturing.
-
2022
May 10
Launch of the Gut Microbiota & Metabolome Analysis service.
Making metabolite analysis more accessible to research and healthcare. Bringing scientific insight closer to society.June 15
Launch of the Gut Microbiota Analysis Service.
Expanding applications across medicine, food, and life science research. Bringing science closer to everyday life. -
2024
Expansion of international scientific collaborations.
Including partnerships with Harvard University, Stanford University, Newcastle University,
and other leading institutions. Science resonating across the world. -
2025
August 8
Collaboration with the Keio University Center for Preventive Medicine.
Introduction of a personalized health assessment program utilizing gut microbiome analysis. A new chapter in preventive healthcare.
September 11
Support for Professor Kazuki Nagashima’s laboratory at Harvard University through a
US$100,000 research donation.
Advancing research on the gut microbiome and immunity. Investing in the science of future generations.December 17
A press conference was held to announce NOSTER’s acquisition of a campus site in Keihanna
Science City.
Together with Kyoto Prefecture and Doshisha University, NOSTER presented its vision for the
future of metabolite science and biotechnology. A place where the future of science begins.